News
Vision RT and DoseOptics partnership to advance Cherenkov Imaging
Following several years of collaboration, DoseOptics LLC, the pioneer of Cherenkov imaging, entered a strategic partnership with Vision RT Limited, the leading provider of SGRT solutions, through which a fully integrated and unique offering combining the two technologies is now provided.
Working together for several years, the two companies have developed DoseRT™ powered by BeamSite® – a radiation therapy monitoring solution that uses Cherenkov imaging to reveal and visualize the radiation dose as it is delivered, working alongside AlignRT® Horizon cameras, which monitor the patient’s position. DoseRT has been through extensive clinical testing and launched commercially in 2025.
The landmark agreement strengthened the long-term commitment between the two companies. The partnership brings together DoseOptics’ leadership in Cherenkov imaging research and development with Vision RT’s leadership in SGRT, product execution and global sales reach.
The two companies continue to collaborate on a range of solutions to improve the safety, effectiveness and efficiency of the entire radiation therapy workflow.
Details on DoseRT™ powered by BeamSite® can be found here.
BeamSite: A New Paradigm in Radiation Delivery
Are you or one of your loved ones planning to undergo radiation therapy? At DoseOptics, we know how daunting and even stressful upcoming treatment can be. This is, in fact, one of the reasons we created BeamSite, a radiation visualization tool designed for clinical use: because we want to assuage any fears for those receiving radiation.
DoseOptics is revolutionizing safe cancer care, and here’s how.
More than 14 million cancer patients receive radiation therapy each year. While significant advancements continue to be made in radiotherapy, errors may still occur during the treatment process.